Study of Immune Senescence and Premature Aging in Two Populations at Higher Risk of Cancer: Elderly People and Perinatally Human Immunodeficiency Virus (HIV)-Infected Children \n
Year: 2015
Type: article
Study design: Observational Study
Abstract: Immune senescence and premature aging are important tumor risk factors. Decline in immune functions and accumulation of DNA damages influence overall health and predispose to malignancies. As a result of longer life expectancy, the number of cancers in the elderly population is expected to increase significantly over the next years. Considering the effect of the growing geriatric population on cancer care, the need to develop prognostic markers for cancer onset and/or chemotherapy response for improved treatment in this frail population is becoming greater. Furthermore, several conditions, such as HIV infection, also appear to accelerate aging and immune senescence; chronic immune activation may play a critical role in these dysfunctions which, besides immune depression, may constitute important risk factors for the onset of HIV-associated tumors. The persistence of a higher incidence of malignancies in HIV-infected individuals compared with the age-matched general population, even after the introduction of antiretroviral therapy (ART), which can reduce HIV levels and partially restore the immune functions, indicates that other conditions than immune depression play a role in the cancerogenesis occurring in HIV-infected patients. This is of particular importance in the perinatally HIV-infected children in whom the immune system co-evolves with HIV from birth. After the introduction of ART, most perinatally HIV-infected children are entering into adolescence and young adulthood and, despite ART, they remain at high risk of malignancies. \nMy PhD project focuses on the study of immune senescence and premature aging in two populations at higher risk of cancer: elderly people and perinatally HIV-infected children. \n \n \n \n1.\tImmune senescence and cancer in elderly people \nThis study analyzed thymic output, immunophenotypic profile of CD4+ and CD8+ lymphocytes and peripheral blood telomere length (TL) in cancer patients 70≥ years old. Fifty-two elderly cancer patients and 39 age-matched controls without personal history of cancer were enrolled. The percentages of CD8+ naïve and CD8+ recent thymic emigrant cells (RTE) cells and levels of TREC (T-cell receptor excision circles, a molecular marker to evaluate thymic output) were significantly lower in cancer patients than in controls (16.7% [9.3-25.2] vs 24.6% [14.7-33.5], p=0.003; 34.2% [24.7-46.4] vs 44.9% [36.0-50.7], p=0.004; 16.0 [7.7-31.5] vs 25.0 [14.0-56.0] TREC copies/105 PBMC, p=0.031; respectively). TLs in peripheral blood mononuclear cells (PBMC) were significantly shorter in cancer patients than they did in controls (p=0.046) and did not correlate with age in patients, whereas it did in controls (r=-0.354, p=0.031). Short telomere(≤median)/low TREC(≤median) profile was associated with a higher risk of cancer (OR=3.68 [95%CI 1.22-11.11]; p=0.021). A longitudinal substudy is in progress to evaluate the effect of these markers on chemotherapy response and/or disease outcome. Preliminary data from this longitudinal substudy showed that, after chemotherapy treatment, there was an increase in CD8+ terminally differentiated cells (p=0.031), and telomere shortening at follow-up tended to be greater in stage III patients than in those at stage II. In addition, analysis of DNA-damage in PBMC, before and after exposure to a source of y-radiation, suggested that the DNA repair process is less efficient in cancer patients than in controls. Taken together, these findings indicate that immune senescence is significantly worse in elderly cancer patients than in age-matched controls. The low thymic output and the short telomeres in peripheral blood cells of cancer patients may reflect a pre-existing condition which facilitates the onset of malignancies in elderly people and may affect the response to chemotherapy and disease outcome. \n2.\tPremature aging in perinatally HIV-infected children \nSeventy-one HIV-infected (HIV+) children born to HIV-infected mothers, aged from 0-5 years, 65 HIV-exposed-uninfected (HEU) born to HIV-infected mothers and 56 HIV-unexposed-uninfected (HUU) age-matched children were studied. 42% of the HIV+ children were not on ART. TLs were significantly shorter in HIV+ than in HEU and HUU children (overall p<0.0001, adjusted for age); in addition, HIV+ ART-naïve children had shorter TLs than children on ART (median 2.11 [interquartile range (IQR) 1.75-2.37] vs 2.46 [2.07-2.68]; p=0.0029 adjusted for age). CD8+ RTE (CD45RA+CD31+) and TREC levels were significantly lower in the HIV+ group than in the HEU and HUU groups (overall, p=0.005 and p=0.0249, respectively), whereas percentages of CD8+ effector memory (CD45RA-CD27-) and terminally differentiated cells (CD45RA+CD27-) were higher in the former (overall, p=0.033, and p<0.001, respectively). CD8+ senescent cells (CD28-CD57+) were higher in HIV+ than in HEU and HUU children (25.8% [12.4-43.2] vs 8.5% [6.8-16.7] vs 9.7% [3.3-27.3]; p=0.004), as were CD8+ activated cells (CD38+HLA-DR+) (7.0% [5.2-12.2] vs 3.5% [3.9-7.6] vs 3.7% [2.4-6.7]; p<0.001) and CD8+PD-1+ cells (7.1% [5.0-12.4] vs 3.5% [2.1-5.9] vs 3.7% [2.4-5.3]; p<0.001). Within the CD4+ cell subset, percentages of senescent cells did not differ between HIV+ and controls, although PD-1 expression tended to be up-regulated in HIV+ children (overall, p=0.050). Overall, these data suggest that HIV-infected children exhibit premature aging and accelerated immune senescence, which particularly affects the CD8+ cell subset. HIV infection per se seems to influence the aging process, rather than exposure to ART for prophylaxis or treatment. The mechanism(s) by means of which HIV may affect these functions remain to be investigated; however, chronic immune activation due to viral antigen persistence may promote rapid proliferation of CD8+ cells, resulting in erosion of telomeres and immunosenescent phenotype. \nConclusions \nTaken together these studies indicate that TL, TREC and immunophenotypic analysis are useful markers in monitoring premature aging and immune senescence. In elderly patients, low thymic output and short telomeres are significantly associated with tumor and may affect the response to chemotherapy. Thus, these markers may be useful in the elderly population to predict tumor onset and to plan therapeutic strategies. In the context of pediatric HIV infection, in addition to current assays, i.e. HIV plasmaviremia and CD4+ cell profile, our study indicates the need to analyze TL and CD8+ cell subsets to assess the status of premature aging and immune senescence in this population at high risk of cancer. \n
Author: Gianesin, Ketty
Language: English
Topic: HIV Research and Treatment
Subfield: Virology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7015297260
